Logo image of ATNF

180 LIFE SCIENCES CORP (ATNF) Stock Overview

USA - NASDAQ:ATNF - US68236V3024 - Common Stock

7.04 USD
-0.57 (-7.49%)
Last: 8/15/2025, 8:06:05 PM
7.29 USD
+0.25 (+3.55%)
After Hours: 8/15/2025, 8:06:05 PM

ATNF Key Statistics, Chart & Performance

Key Statistics
Market Cap42.52M
Revenue(TTM)N/A
Net Income(TTM)-17217500
Shares6.04M
Float2.40M
52 Week High17.75
52 Week Low0.66
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-12.78
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO2017-06-07
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ATNF short term performance overview.The bars show the price performance of ATNF in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 100 200 300 400

ATNF long term performance overview.The bars show the price performance of ATNF in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 100 200

The current stock price of ATNF is 7.04 USD. In the past month the price increased by 274.47%. In the past year, price increased by 291.11%.

180 LIFE SCIENCES CORP / ATNF Daily stock chart

ATNF Latest News, Press Relases and Analysis

ATNF Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.49 401.96B
AMGN AMGEN INC 13.39 157.25B
GILD GILEAD SCIENCES INC 15.23 146.27B
VRTX VERTEX PHARMACEUTICALS INC 24.93 108.30B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 62.38B
REGN REGENERON PHARMACEUTICALS 14.34 69.37B
ARGX ARGENX SE - ADR 90.81 51.50B
INSM INSMED INC N/A 34.94B
ONC BEONE MEDICINES LTD-ADR 5.11 34.80B
NTRA NATERA INC N/A 26.02B
BNTX BIONTECH SE-ADR N/A 25.25B
BIIB BIOGEN INC 9.31 21.86B

About ATNF

Company Profile

ATNF logo image 180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.

Company Info

180 LIFE SCIENCES CORP

3000 El Camino Real, Bldg 4, Ste 200

Palo Alto CALIFORNIA 10019 US

CEO: James N. Woody

Employees: 4

ATNF Company Website

ATNF Investor Relations

Phone: 16505070669

180 LIFE SCIENCES CORP / ATNF FAQ

What does 180 LIFE SCIENCES CORP do?

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.


What is the stock price of 180 LIFE SCIENCES CORP today?

The current stock price of ATNF is 7.04 USD. The price decreased by -7.49% in the last trading session.


Does ATNF stock pay dividends?

ATNF does not pay a dividend.


How is the ChartMill rating for 180 LIFE SCIENCES CORP?

ATNF has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What sector and industry does 180 LIFE SCIENCES CORP belong to?

180 LIFE SCIENCES CORP (ATNF) operates in the Health Care sector and the Biotechnology industry.


What is 180 LIFE SCIENCES CORP worth?

180 LIFE SCIENCES CORP (ATNF) has a market capitalization of 42.52M USD. This makes ATNF a Nano Cap stock.


Can you provide the upcoming earnings date for 180 LIFE SCIENCES CORP?

180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.


ATNF Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ATNF. When comparing the yearly performance of all stocks, ATNF is one of the better performing stocks in the market, outperforming 99.56% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ATNF Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ATNF. Both the profitability and financial health of ATNF have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATNF Financial Highlights

Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -12.78. The EPS increased by 54.65% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -160.7%
ROE -319.99%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%-3125%
Sales Q2Q%N/A
EPS 1Y (TTM)54.65%
Revenue 1Y (TTM)N/A

ATNF Forecast & Estimates


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y0%
Revenue Next Year54.15%

ATNF Ownership

Ownership
Inst Owners1.07%
Ins Owners28.84%
Short Float %N/A
Short RatioN/A